SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019915
Filing Date
2021-08-16
Accepted
2021-08-16 08:01:22
Documents
77
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1069259
2 ex10-2.htm EX-10.2 115478
3 ex31-1.htm EX-31.1 17229
4 ex31-2.htm EX-31.2 17341
5 ex32-1.htm EX-32.1 9438
  Complete submission text file 0001493152-21-019915.txt   6274477

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ghsi-20210630.xsd EX-101.SCH 48443
7 XBRL CALCULATION FILE ghsi-20210630_cal.xml EX-101.CAL 62660
8 XBRL DEFINITION FILE ghsi-20210630_def.xml EX-101.DEF 214648
9 XBRL LABEL FILE ghsi-20210630_lab.xml EX-101.LAB 425537
10 XBRL PRESENTATION FILE ghsi-20210630_pre.xml EX-101.PRE 334724
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 992675
Mailing Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address 15150 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 211174605
SIC: 2834 Pharmaceutical Preparations